Patient demographics
| Group | n | Sex (male/female) | Age (years) | GADA | Anti-IA2 | Duration (years) |
|---|---|---|---|---|---|---|
| New-onset type 1 diabetes* | 14 | 8/6 | 14.1 ± 4.1 | 12/14 | 9/14 | 0.11 ± 0.07 |
| Median (range) | 13.5 (8.4–23.5) | 0.11 (0.01–0.24) | ||||
| Established type 1 diabetes† | 17 | 10/7 | 18.1 ± 10.2 | 15/17 | 12/17 | 7.0 ± 9.8 |
| Median (range) | 13.5 (8.4–23.5) | 3.6 (1.0–38.2) | ||||
| First-degree relatives | 46 | 22/24 | 27.7 ± 17.5 | 4/46 | 5/46 | |
| Median (range) | 33.9 (3.5–62.6) | |||||
| Healthy control subjects | 33 | 16/17 | 23.4 ± 10.1 | 0/32‡ | 0/32‡ | |
| Median (range) | 21.9 (6.3–44.9) |
Data are means ± SD and n unless otherwise indicated.
* New-onset type 1 diabetic patients were analyzed within 3 months of the date of diagnosis.
† The established type 1 diabetic group contained all subjects with disease duration >3 months.
‡ Serum was not available for one control subject.